Down-Regulation of Vitamin D Receptor in Mammospheres: Implications for Vitamin D Resistance in Breast Cancer and Potential for Combination Therapy

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Pervin, Shehla ^a,b   Hewison, Martin ^b   Braga, Melissa ^a   Tran, Lac ^a   Chun, Rene ^b   Karam, Amer ^b   Chaudhuri, Gautam ^b   Norris, Keith ^a   Singh, Rajan ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; ALDEHYDE DEHYDROGENASE; DETA NANOIC ACID; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NITRIC OXIDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; VITAMIN D RECEPTOR;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CANCER TRANSPLANTATION; CELL ACTIVITY; CELL SIZE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME INDUCTION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEPHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SEPARATION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMARY GLANDS, HUMAN; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; NITRIC OXIDE; RECEPTORS, CALCITRIOL; RETINOID X RECEPTORS; SPHEROIDS, CELLULAR; TRANSCRIPTION FACTORS; UP-REGULATION; VITAMIN D; XENOGRAFT MODEL ANTITUMOR ASSAYS;

GASTROPODA; MUS MUSCULUS;

EID: 84872325180     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053287     Document Type: Article

References (48)

1. Toner CD, Davis CD, Milner JA, (2010) The vitamin D and cancer conundrum: aiming at a moving target J AM DIET ASSOC. 110: 1492-1500.
2. Pérez-López FR, Chedraui P, Haya J, (2009) Review article: vitamin D acquisition and breast cancer risk. Reprod Sci 16: 7-19.
3. Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, et al. (2007) Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res 9: R84.
4. Alimirah F, Peng X, Murillo G, Mehta RG, (2011) Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. PLoS One 6(1): e16024.
5. McKay JD, McCullough ML, Ziegler RG, Kraft P, Saltzman BS, et al. (2009) Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 18: 297-305.
6. Krishnan AV, Swami S, Feldman D, (2010) Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol 121: 343-348.
7. Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, et al. (1994) Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31: 191-202.
8. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988.
9. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, et al. (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69: 1302-1313.
10. Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, et al. (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140: 62-73.
11. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507.
12. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, et al. (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 106: 13820-13825.
13. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, et al. (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672-679.
14. Eyler CE, Rich JN, (2008) Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol 26: 2839-45.
15. Larriba MJ, Bonilla F, Muñoz A, (2010) The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression. J Steroid Biochem Mol Biol 121: 106-109.
16. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270.
17. Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, et al. (2006) Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147: 141-154.
18. Braga M, Bhasin S, Jasuja R, Pervin S, Singh R, (2012) Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: potential role of follistatin in mediating testosterone action. Mol Cell Endocrinol 5 350(1): 39-52.
19. Liu N, Kaplan AT, Low J, Nguyen L, Liu GY, et al. (2009) Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod 80: 398-406.
20. Sancéau J, Poupon MF, Delattre O, Sastre-Garau X, Wietzerbin J, (2002) Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide. Oncogene 21(50): 7700-9.
21. Samuni Y, Flores-Santana W, Krishna MC, Mitchell JB, Wink DA, (2009) The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation. Free Radic Biol Med 47: 419-423.
22. Pervin S, Singh R, Freije WA, Chaudhuri G, (2003) MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer. Cancer Res 63: 8853-8860.
23. Jeanson NT, Scadden DT, (2010) Vitamin D receptor deletion leads to increased hematopoietic stem and progenitor cells residing in the spleen. Blood 116: 4126-4129.
24. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
25. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037.
26. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, et al. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973-978.
27. To K, Fotovati A, Reipas KM, Law JH, Hu K, et al. (2010) Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Res 70: 284028-51.
28. Kommagani R, Caserta TM, Kadakia MP, (2006) Identification of vitamin D receptor as a target of p63. Oncogene 25: 3745-3751.
29. Kemmis CM, Welsh J, (2008) Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J Cell Biochem 105: 980-988.
30. Narvaez CJ, Zinser G, Welsh J, (2001) Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer. Steroids 66: 301-308.
31. Lopes N, Sousa B, Martins D, Gomes M, Vieira D, et al. (2010) Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer 10: 483.
32. Li Y, Wicha MS, Schwartz SJ, Sun D, (2011) Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds. J Nutr Biochem 22: 799-806.
33. Jensen JD, Wing GJ, Dellavalle RP, (2010) Nutrition and melanoma prevention. Clin Dermatol 28: 644-649.
34. Yin L, Grandi N, Raum E, Haug U, Arndt V, et al. (2011) Meta-analysis: Circulating vitamin D and ovarian cancer risk. Gynecol Oncol 121: 369-375.
35. Johnson J, de Mejia EG, (2011) Dietary factors and pancreatic cancer: the role of food bioactive compounds. Mol Nutr Food Res 55: 58-73.
36. Mittal MK, Myers JN, Misra S, Bailey CK, Chaudhuri G, (2008) In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 372: 30-34.
37. Bai S, Wang H, Shen J, Zhou R, Bushinsky DA, et al. (2010) Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with down regulation of Snail. J Bone Miner Res 25: 830-840.
38. Larriba MJ, Muñoz A (2005) SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications. Br J Cancer. 92: 985-9. Review.
39. Abedin SA, Banwell CM, Colston KW, Carlberg C, Campbell MJ. Epigenetic corruption of VDR signalling in malignancy. Anticancer Res 26: 2557-2566.
40. Tavera-Mendoza LE, Quach TD, Dabbas B, Hudon J, Liao X, et al. (2008) Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist. Proc Natl Acad Sci USA 105: 8250-5.
41. Pervin S, Singh R, Chaudhuri G, (2001) Nitric Oxide induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): Potential role of Cyclin D1. Proc. Nat. Acad. Sci. USA 98: 3583-3588.
42. Pervin S, Singh R, Chaudhuri G, (2003) Nitric-oxide-induced Bax integration into the mitochondrial membrane commits MDA-MB-468 cells to apoptosis: essential role of Akt. Cancer Res 63: 5470-5479.
43. Zhang Z, Kovalenko P, Cui M, Desmet M, Clinton SK, et al. (2010) Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells. J Cell Physiol 224: 433-444.
44. Muindi JR, Peng Y, Potter DM, Hershberger PA, Tauch JS, et al. (2002) Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. Clin Pharmacol Ther. 72: 648-659.
45. Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, et al. (2007) A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors. Clin Cancer Res. 13: 1216-1223.
46. Yu WD, McElwain MC, Modzelewski RA, Russell DM, Smith DC, et al. (1998) Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst. 90: 134-141.
47. Krishnan AV, Swami S, Peng L, Wang J, Moreno J, et al. (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 151: 32-42.
48. Swami S, Krishnan AV, Wang JY, Jensen K, Peng L, et al. (2011) Inhibitory Effects of Calcitriol on the Growth of MCF-7 Breast Cancer Xenografts in Nude Mice: Selective Modulation of Aromatase Expression in vivo. Horm Cancer 2: 190-202.